Skip to Content

We invite you to try out our new beta eCFR site at We’ve made big changes to make the eCFR easier to use. Be sure to leave feedback using the 'Feedback' button on the bottom right of each page!


Advisory Committee; Renewals

Document Details

Information about this document as published in the Federal Register.

Document Statistics
Document page views are updated periodically throughout the day and are cumulative counts for this document. Counts are subject to sampling, reprocessing and revision (up or down) throughout the day.
Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble


Food and Drug Administration, HHS.




The Food and Drug Administration (FDA) is announcing the renewal of certain FDA advisory committees by the Commissioner of Food and Drugs (the Commissioner). The Commissioner has determined that it is in the public interest to renew the charters of the committees listed below for an additional 2 years beyond charter expiration date. The new charters will be in effect until the dates of expiration listed below. This notice is issued under the Federal Advisory Committee Act of October 6, 1972 (Pub. L. 92-463 (5 U.S.C. app. 2)).


Authority for these committees will expire on the date indicated below unless the Commissioner formally determines that renewal is in the public interest.

Name of committeeDate of expiration
Antiviral Drugs Advisory Committee.Feb. 15, 2003.
National Mammography Quality Assurance Advisory Committee,July 6, 2003.
Nonprescription Drugs Advisory Committee.Oct. 27, 2003.
Advisory Committee on Special Studies Relating to the Possible Long-Term Health Effects of Phenoxy Herbicides and Contaminants.Dec. 2, 2003.
Food Advisory CommitteeDec. 18, 2003.
Vaccines and Related Biological Products Advisory. CommitteeDec. 31, 2003.
Advisory Committee for Pharmaceutical Science.Jan. 22, 2004.
Pharmacy Compounding Advisory Committee.Feb. 3, 2004.
Start Further Info


Linda A. Sherman, Advisory Committee Oversight and Management Staff (HF-4), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-1220.

Start Signature

Dated: March 5, 2002.

Linda A. Suydam,

Senior Associate Commissioner for Communications and Constituent Relations.

End Signature End Further Info End Preamble

[FR Doc. 02-5791 Filed 3-11-02; 8:45 am]